The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
9707 E. Easter Lane
Centennial, CO 80112 USA
The National Stroke Association (NSA) is a national, non-profit, voluntary health organization dedicated to reducing the incidence and impact of stroke by changing the way it is viewed and treated. During a stroke, interruption of oxygenated blood supply to the brain or leakage of blood outside of blood vessel walls may cause damage to a portion of the brain. Depending upon the exact location and duration of lack of oxygenated blood supply to brain tissue (ischemia), affected individuals may experience a variety of symptoms such as weakness, paralysis, speech impairment, sensory abnormalities, and/or life-threatening complications. Established in 1984, the National Stroke Association promotes patient, physician, and public education; engages in patient advocacy efforts; and promotes research into improved stroke prevention, treatment, and rehabilitation. The organization, which currently has 14 chapters and approximately 7,000 members, offers networking services that enable affected individuals and family members to exchange information, assistance, and support; maintains a registry; offers support groups; and makes appropriate referrals. In addition, the NSA offers a stroke information hotline and provides a variety of materials including reports, brochures, pamphlets, videos, audiovisual aids, and a quarterly newsletter.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.